Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents ; volume:7 ; number:1 ; day:15 ; month:10 ; year:2014 ; pages:1-8 ; date:12.2014
Journal of hematology & oncology ; 7, Heft 1 (15.10.2014), 1-8, 12.2014
- Urheber
-
Parikh, Kaushal
Cang, Shundong
Sekhri, Arunabh
Liu, Delong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-014-0078-0
- URN
-
urn:nbn:de:101:1-2021082821191239480293
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-15T07:24:32+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Parikh, Kaushal
- Cang, Shundong
- Sekhri, Arunabh
- Liu, Delong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Thiadiazole derivatives as anticancer agents
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Selective amyloid-β lowering agents
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Thiadiazole derivatives as anticancer agents
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Selective amyloid-β lowering agents
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Thiadiazole derivatives as anticancer agents
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Selective amyloid-β lowering agents
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents